Release date: 18 March 2024
Promoter – Financial Intermediary
RESOLVE BIOSCIENCES BVLocation
Description
The project supports the promoter's activities related to research, development (R&D), regulatory requirements, and commercialisation, as well as IPs of its innovative High Resolution Pathology technology.
Objectives
The aim is to support the R&D activities of the Promoter, including IP, regulatory and other investments related to the development of its technology based on spatial biology, as well as the market entry of its innovative products in a clinical use and drug development context.
Sector(s)
- Industry - Manufacturing
Proposed EIB finance (Approximate amount)
EUR 30 million
Total cost (Approximate amount)
EUR 70 million
Environmental aspects
The concerned R&D activities are expected to be carried out in the Promoter's existing facilities or other research centers already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under the Directive 2014/52/EU amending the EIA Directive 2011/92/EU. Full environmental details will be verified during the appraisal by the EIB for compliance of the project with the relevant European legislation.
Procurement
The Bank will require that all project contracts are procured in accordance with the applicable EU procurement legislation.
Status
Under appraisal
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).